Microfluidic enrichment for the single cell analysis of circulating tumor cells
Circulating tumor cell
Single-Cell Analysis
T790M
DOI:
10.1038/srep22076
Publication Date:
2016-02-29T12:07:16Z
AUTHORS (12)
ABSTRACT
Abstract Resistance to drug therapy is a major concern in cancer treatment. To probe clones resistant chemotherapy, the current approach conduct pooled cell analysis. However, this can yield false negative outcomes, especially when we are analyzing rare number of circulating tumor cells (CTCs) among an abundance other types. Here, develop microfluidic device that able perform high throughput, selective picking and isolation single CTC 100% purity from larger population cells. This effectively separate very CTCs blood samples as few 1 20,000 white We first demonstrate pure mixed track variations acquired T790M mutations before after treatment using model PC9 line. With clinical samples, then show isolated representative dominant EGFR such L858R found primary tumor. recovery device, potentially implement personalized not only through detecting genetic aberrations at level, but also tracking changes during anticancer therapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (64)
CITATIONS (103)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....